Literature DB >> 14982589

Prevalence of the breed-related glaucomas in pure-bred dogs in North America.

Kirk N Gelatt1, Edward O MacKay.   

Abstract

OBJECTIVE: To determine the prevalence of the breed-related glaucomas in pure-bred dogs presented to the veterinary medical teaching hospitals in North America that participate in the Veterinary Medical Data Base (VMDB).
MATERIALS AND METHODS: In this retrospective study, age of first diagnosis, breed, and gender data for all breeds of dogs were collected from the VMDB with the clinical diagnosis of primary glaucoma (glaucoma-NOS) at 5-10 year intervals from 1964 to 2002. The prevalence for each breed (affected dogs compared to all dogs of each breed), any changes over the 38 years, and any gender differences for these glaucomas were determined.
RESULTS: The prevalence of the primary breed-related glaucomas has gradually increased from 0.29% (1964-1973); 0.46% (1974-1983); 0.76% (1984-1993); to 0.89% (1994-2002). Breeds that consistently featured among the highest 10 for glaucoma prevalence from four different periods (1964 to 2002) included American Cocker Spaniel, Basset Hound, Wire Fox Terrier, and Boston Terrier. During the last observation period (1994-2002), 22 different breeds had 1% or higher prevalence of the glaucomas. The highest prevalence of glaucomas in 1994-2002 by breed included: American Cocker Spaniel (5.52%); Basset Hound (5.44%); Chow Chow (4.70%); Shar-Pei (4.40%); Boston Terrier (2.88%); Wire Fox Terrier (2.28%); Norwegian ElkHound (1.98%); Siberian Husky (1.88%); Cairn Terrier (1.82%); and Miniature Poodle (1.68%). A predominance of females with glaucoma occurred in the American Cocker Spaniel, Basset Hound, Cairn Terrier, Chow Chow, English Cocker Spaniel, Samoyed, and perhaps the Siberian Husky, and a predominance of males in the Australian Cattle dog and St Bernard. Age affected the time for first presentation of the glaucomas in the pure-bred dog. In the majority of breeds the glaucomas were presented for initial diagnosis in dogs between 4 and 10 years of age.
CONCLUSION: Breed-related glaucomas in pure-bred dogs are frequently presented to the veterinary medical teaching hospitals in North America. The prevalence of the breed-related glaucomas in the dog appears similar to humans, and in some breeds exceeds that in humans. In many breeds the high prevalence of the glaucomas suggests a genetic basis.

Entities:  

Mesh:

Year:  2004        PMID: 14982589     DOI: 10.1111/j.1463-5224.2004.04006.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  22 in total

1.  Screening ADAMTS10 in dog populations supports Gly661Arg as the glaucoma-causing variant in beagles.

Authors:  John Kuchtey; Jessica Kunkel; Douglas Esson; John S Sapienza; Daniel A Ward; Caryn E Plummer; Kirk N Gelatt; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-13       Impact factor: 4.799

2.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

Review 3.  Insurance data for research in companion animals: benefits and limitations.

Authors:  Agneta Egenvall; Ane Nødtvedt; Johanna Penell; Lotta Gunnarsson; Brenda N Bonnett
Journal:  Acta Vet Scand       Date:  2009-10-29       Impact factor: 1.695

Review 4.  Clinical Signs and Diagnosis of the Canine Primary Glaucomas.

Authors:  Paul E Miller; Ellison Bentley
Journal:  Vet Clin North Am Small Anim Pract       Date:  2015-11       Impact factor: 2.093

5.  Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Kuan-Ting Lin; Juan P Steibel; Christine D Harman; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2019-12-24       Impact factor: 1.644

6.  Animal models of scarring control.

Authors:  David L Williams
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

7.  Safety and efficacy of topically administered netarsudil-latanoprost fixed dose combination (FDC; Rocklatan™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Juan P Steibel; Christine D Harman; Amanda L Anderson; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2021-06-04       Impact factor: 1.644

Review 8.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

9.  Development and validation of methods to visualize conventional aqueous outflow pathways in canine primary angle closure glaucoma.

Authors:  Mary Rebecca Telle; Kevin C Snyder; Kazuya Oikawa; Jacob P Nilles; Shaile Gehrke; Leandro B C Teixeira; Julie A Kiland; Alex Huang; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2021-09-28       Impact factor: 1.444

10.  Exclusion of eleven candidate genes for ocular melanosis in Cairn terriers.

Authors:  Paige A Winkler; Joshua T Bartoe; Celeste R Quinones; Patrick J Venta; Simon M Petersen-Jones
Journal:  J Negat Results Biomed       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.